Literature DB >> 25103529

Analysis of drug interactions with very low density lipoprotein by high-performance affinity chromatography.

Matthew R Sobansky1, David S Hage.   

Abstract

High-performance affinity chromatography (HPAC) was utilized to examine the binding of very low density lipoprotein (VLDL) with drugs, using R/S-propranolol as a model. These studies indicated that two mechanisms existed for the binding of R- and S-propranolol with VLDL. The first mechanism involved non-saturable partitioning of these drugs with VLDL, which probably occurred with the lipoprotein's non-polar core. This partitioning was described by overall affinity constants of 1.2 (±0.3) × 10(6) M(-1) for R-propranolol and 2.4 (±0.6) × 10(6) M(-1) for S-propranolol at pH 7.4 and 37 °C. The second mechanism occurred through saturable binding by these drugs at fixed sites on VLDL, such as represented by apolipoproteins on the surface of the lipoprotein. The association equilibrium constants for this saturable binding at 37 °C were 7.0 (±2.3) × 10(4) M(-1) for R-propranolol and 9.6 (±2.2) × 10(4) M(-1) for S-propranolol. Comparable results were obtained at 20 and 27 °C for the propranolol enantiomers. This work provided fundamental information on the processes involved in the binding of R- and S-propranolol to VLDL, while also illustrating how HPAC can be used to evaluate relatively complex interactions between agents such as VLDL and drugs or other solutes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25103529      PMCID: PMC4167910          DOI: 10.1007/s00216-014-8081-4

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  30 in total

1.  Enantioselective binding analysis of verapamil to plasma lipoproteins by capillary electrophoresis-frontal analysis.

Authors:  N A Mohamed; Y Kuroda; A Shibukawa; T Nakagawa; S El Gizawy; H F Askal; M E El Kommos
Journal:  J Chromatogr A       Date:  2000-04-14       Impact factor: 4.759

Review 2.  High-performance affinity chromatography: a powerful tool for studying serum protein binding.

Authors:  David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-02-25       Impact factor: 3.205

3.  Evaluation of the human serum albumin column as a discovery screening tool for plasma protein binding.

Authors:  Lisa Buchholz; Chun-Hua Cai; Larry Andress; Adriaan Cleton; Joanne Brodfuehrer; Lucinda Cohen
Journal:  Eur J Pharm Sci       Date:  2002-03       Impact factor: 4.384

4.  Binding analysis of nilvadipine to plasma lipoproteins by capillary electrophoresis-frontal analysis.

Authors:  N A Mohamed; Y Kuroda; A Shibukawa; T Nakagawa; S El Gizawy; H F Askal; M E El Kommos
Journal:  J Pharm Biomed Anal       Date:  1999-12       Impact factor: 3.935

5.  Effect of oxidation of low-density lipoprotein on drug binding affinity studied by high performance frontal analysis-capillary electrophoresis.

Authors:  Y Kuroda; B Cao; A Shibukawa; T Nakagawa
Journal:  Electrophoresis       Date:  2001-10       Impact factor: 3.535

6.  Frontal analysis of drug-plasma lipoprotein binding using capillary electrophoresis.

Authors:  Takanori Ohnishi; Niveen Abdel Latif Mohamed; Akimasa Shibukawa; Yukihiro Kuroda; Terumichi Nakagawa; Samia El Gizawy; Hassan F Askal; Micheal E El Kommos
Journal:  J Pharm Biomed Anal       Date:  2002-01-15       Impact factor: 3.935

7.  Propranolol in hypertension. Report on 158 patients treated up to one year.

Authors:  L Hansson; R Malmcrona; R Olander; L Rosenhall; A Westerlund; H Aberg; B Hood
Journal:  Klin Wochenschr       Date:  1972-04-01

8.  A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris.

Authors:  A R Hebb; T F Godwin; R W Gunn
Journal:  Can Med Assoc J       Date:  1968-02-03       Impact factor: 8.262

9.  The distribution of bound propranolol between the different human serum proteins.

Authors:  S Glasson; R Zini; P d'Athis; J P Tillement; J R Boissier
Journal:  Mol Pharmacol       Date:  1980-03       Impact factor: 4.436

Review 10.  Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance.

Authors:  Carlo Bertucci; Enrico Domenici
Journal:  Curr Med Chem       Date:  2002-08       Impact factor: 4.530

View more
  6 in total

Review 1.  High performance affinity chromatography and related separation methods for the analysis of biological and pharmaceutical agents.

Authors:  Chenhua Zhang; Elliott Rodriguez; Cong Bi; Xiwei Zheng; Doddavenkatana Suresh; Kyungah Suh; Zhao Li; Fawzi Elsebaei; David S Hage
Journal:  Analyst       Date:  2018-01-15       Impact factor: 4.616

Review 2.  Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective.

Authors:  Zhao Li; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2017-01-11       Impact factor: 3.935

3.  Entrapment of alpha1-acid glycoprotein in high-performance affinity columns for drug-protein binding studies.

Authors:  Cong Bi; Abby Jackson; John Vargas-Badilla; Rong Li; Giana Rada; Jeanethe Anguizola; Erika Pfaunmiller; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-11-27       Impact factor: 3.205

Review 4.  Analysis of Biological Interactions by Affinity Chromatography: Clinical and Pharmaceutical Applications.

Authors:  David S Hage
Journal:  Clin Chem       Date:  2017-04-10       Impact factor: 8.327

5.  Chromatographic Studies of Protein-Based Chiral Separations.

Authors:  Cong Bi; Xiwei Zheng; Shiden Azaria; Sandya Beeram; Zhao Li; David S Hage
Journal:  Separations       Date:  2016-09-05

6.  Modeling the Distribution of Diprotic Basic Drugs in Liposomal Systems: Perspectives on Malaria Nanotherapy.

Authors:  Ernest Moles; Maria Kavallaris; Xavier Fernàndez-Busquets
Journal:  Front Pharmacol       Date:  2019-09-25       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.